Hypodermic Needles Are Obsolete
Needle phobia, patient comfort, and imperfect drug performance are major problems for patients and health systems.
We are developing the next generation of microneedle technology for intradermal delivery of vaccines and biologics. These devices are easy and comfortable to use, remove the dreaded needle, and target the biologically rich upper dermis to make today's drugs better today.
Customize. Integrate. Commercialize.
The Microdermics microneedle technology is built upon a proprietary process that enables large-volume production and low cost-of-goods. Scale-up to commercially-ready status of ongoing through Q2 & Q3 of 2017.
- No visible needle for improved patient experience
- Eliminates needle fear and needlestick injuries
- Specifically targets the superficial dermis
Built to Scale
Our microneedles are highly versatile and customizable, with variable microneedle length, diameter, and configuration. They are the only commercially scalable, customizable, and versatile, metal, hollow, microneedle platform for efficient delivery of vaccines and biologics using conventional syringes, auto-injectors, and smart pens.